Carnegie Capital Asset Management LLC lessened its stake in Exponent, Inc. (NASDAQ:EXPO – Get Rating) by 58.7% during the second quarter, HoldingsChannel.com reports. The firm owned 3,001 shares of the business services provider's stock after selling 4,271 shares during the period. Carnegie Capital Asset Management LLC's holdings in Exponent were worth $268,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Cambridge Investment Research Advisors Inc. grew its position in shares of Exponent by 2.5% during the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 15,626 shares of the business services provider's stock valued at $1,429,000 after buying an additional 374 shares during the last quarter. Riverbridge Partners LLC grew its position in shares of Exponent by 1.0% during the 2nd quarter. Riverbridge Partners LLC now owns 1,123,426 shares of the business services provider's stock valued at $102,760,000 after buying an additional 10,664 shares during the last quarter. State of Alaska Department of Revenue grew its position in shares of Exponent by 8.0% during the 2nd quarter. State of Alaska Department of Revenue now owns 39,209 shares of the business services provider's stock valued at $3,586,000 after buying an additional 2,890 shares during the last quarter. Bank of America Corp DE grew its position in shares of Exponent by 1.0% during the 1st quarter. Bank of America Corp DE now owns 227,519 shares of the business services provider's stock valued at $24,584,000 after buying an additional 2,247 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in shares of Exponent by 111.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 4,078 shares of the business services provider's stock valued at $441,000 after buying an additional 2,145 shares during the last quarter. Institutional investors and hedge funds own 90.41% of the company's stock.

Exponent Stock Down 0.6 %

Shares of NASDAQ:EXPO opened at $88.66 on Friday. Exponent, Inc. has a fifty-two week low of $80.97 and a fifty-two week high of $127.61. The company has a market cap of $4.59 billion, a PE ratio of 46.91 and a beta of 0.59. The firm has a 50-day simple moving average of $96.02 and a 200 day simple moving average of $95.45.

Exponent Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 23rd. Investors of record on Friday, September 9th were paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 1.08%. The ex-dividend date was Thursday, September 8th. Exponent's dividend payout ratio is presently 50.79%.

Insider Activity at Exponent

In related news, VP Richard Reiss sold 2,509 shares of the stock in a transaction that occurred on Monday, August 22nd. The shares were sold at an average price of $101.92, for a total transaction of $255,717.28. Following the completion of the sale, the vice president now directly owns 6,329 shares of the company's stock, valued at $645,051.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, VP Richard Reiss sold 2,509 shares of the company's stock in a transaction that occurred on Monday, August 22nd. The shares were sold at an average price of $101.92, for a total value of $255,717.28. Following the completion of the sale, the vice president now owns 6,329 shares in the company, valued at approximately $645,051.68. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Maureen T. F. Reitman sold 3,000 shares of the company's stock in a transaction that occurred on Monday, August 8th. The shares were sold at an average price of $98.90, for a total transaction of $296,700.00. Following the completion of the sale, the vice president now owns 29,444 shares of the company's stock, valued at approximately $2,912,011.60. The disclosure for this sale can be found here. Insiders sold a total of 11,743 shares of company stock valued at $1,173,117 over the last ninety days. Insiders own 2.00% of the company's stock.

About Exponent

(Get Rating)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

See Also

• Get a free copy of the StockNews.com research report on Exponent (EXPO)
• Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
• MarketBeat: Week in Review 9/19 – 9/23
• Why Does Tesla Stock Remain Resilient?
• Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
• Is Costco's Post-Earnings Price Weakness A Good Time To Buy?

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Get Rating).

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.